The enigma of primary biliary cirrhosis

被引:0
作者
Carlo Selmi
Yasunori Ichiki
Pietro Invernizzi
Mauro Podda
M. Eric Gershwin
机构
[1] University of California at Davis,Division of Rheumatology, Allergy, and Clinical Immunology
[2] University of Milan,Division of Internal Medicine, Department of Medicine, Surgery and Dentistry, San Paolo School of Medicine
来源
Clinical Reviews in Allergy & Immunology | 2005年 / 28卷
关键词
Primary biliary cirrhosis; etiology; pathogenesis; auto-antibodies;
D O I
暂无
中图分类号
学科分类号
摘要
Primary biliary cirrhosis (PBC) is a chronic cholestatic disease characterized by a striking predominance in female patients (with most cases diagnosed between ages 40 and 60 yr) as well as serum auto-antibodies to mitochondrial antigens, elevated serum immunoglobulin M, progressive destruction of intrahepatic bile ducts, and, ultimately, liver cirrhosis and failure (1). The precise mechanisms leading to selective destruction of biliary epithelial cells lining intrahepatic bile ducts are still unknown, although numerous immunomediated pathways have been proposed. Genetic background appears to be important in determining susceptibility to the disease (2), but no clear association with alleles in the major histocompatibility complex has been identified. Molecular mimicry either by infections (3) or xenobiotics (4) has been proposed to be capable of breaking tolerance in genetically predisposed individuals, thus leading to onset of PBC. This article describes and discusses the available data regarding the immunomediated pathogenesis of PBC (with particular attention to auto-antibodies and autoreactive T-cells) and presents the recent evidence indicating a role for either xenobiotic chemicals or novel infectious agents in the induction of the disease.
引用
收藏
页码:73 / 81
页数:8
相关论文
共 251 条
[1]  
Kaplan M. M.(1996)undefined N Engl J Med 335 1570-1580
[2]  
Tanaka A.(2001)undefined Am J Gastroenterol 96 8-15
[3]  
Borchers A.T.(2001)undefined Hepatology 33 771-775
[4]  
Ishibashi H.(2001)undefined J Immunol 167 2956-2963
[5]  
Ansari A. A.(2004)undefined Autoimmun Rev 3 493-499
[6]  
Keen C. L.(2001)undefined Nat Immunol 2 777-780
[7]  
Gershwin M. E.(2004)undefined J Clin Gastroenterol 38 264-271
[8]  
Van de Water J.(2002)undefined Genes Immun 3 235-249
[9]  
Ishibashi H.(2004)undefined Lancet Neurol 3 104-110
[10]  
Coppel R. L.(1990)undefined J Immunol 144 3367-3374